Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasovist MRA in Peripheral Artery Disease
NCT00296855Phase 3Completed
- Sponsor
- Bayer
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of gadofosveset in peripheral vascular disease (PVD), sponsored by Bayer. Started Feb 2006; status: completed.
02
Drugs
gadofosveset
03
Conditions
peripheral vascular disease (PVD)
Beyond the preview
Go deeper on NCT00296855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00296855.